Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lepri

Showing results (871-880 of 959) with videos related to

Pageof 96
Sort By:
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Nature Communications|August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIVAlessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2022
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysisIlaria Mastrorosa, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Rheumatology (Oxford, England)|June 16, 2022
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung diseaseCosimo Bruni, Mariaelena Occhipinti, Michael Pienn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
The Journal of Infectious Diseases|September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
Nature Communications|January 19, 2020
Machine learning can identify newly diagnosed patients with CLL at high risk of infectionRudi Agius, Christian Brieghel, Michael A Andersen, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 96

Showing results (871-880 of 959) with videos related to

Sort By:
Pageof 96
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Journal of Medical Virology|October 3, 2022
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agentsValentina Mazzotta, Alessandro Cozzi Lepri, Francesca Colavita, et al.
Nature Communications|August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIVAlessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 20, 2020
The importance of patients' case-mix for the correct interpretation of the hospital fatality rate in COVID-19 diseaseAntonella d'Arminio Monforte, Alessandro Tavelli, Francesca Bai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 2, 2022
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysisIlaria Mastrorosa, Alessandro Cozzi-Lepri, Francesca Colavita, et al.
Rheumatology (Oxford, England)|June 16, 2022
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung diseaseCosimo Bruni, Mariaelena Occhipinti, Michael Pienn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European CohortAnnegret Pelchen-Matthews, Álvaro H Borges, Joanne Reekie, et al.
The Journal of Infectious Diseases|September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
Nature Communications|January 19, 2020
Machine learning can identify newly diagnosed patients with CLL at high risk of infectionRudi Agius, Christian Brieghel, Michael A Andersen, et al.
Vaccines|April 23, 2022
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19Antonella d'Arminio Monforte, Alessandro Tavelli, Sara De Benedittis, et al.
Pageof 96